Table VII.
Seroconversion rates of HPV subtypes at different time points following application of paiteling.
| Seroconversion cases, n (%) | |||||
|---|---|---|---|---|---|
| HPV subtype | Total cases | 6 months | 9 months | 12 months | Note |
| 16 | 38 | 25 (67.7) | 29 (78.4) | 30 (85.7) | One lost; two lost at 12 months |
| 52 | 20 | 17 (89.5) | 18 (94.7) | 19 (100.0) | One lost |
| 58 | 16 | 15 (93.8) | 15 (93.8) | 16 (100.0) | |
| 53 | 10 | 8 (80.0) | 10 (100.0) | 10 (100.0) | |
| 39 | 9 | 9 (100.0) | 9 (100.0) | 9 (100.0) | |
| 33 | 6 | 3 (75.0) | 3 (75.0) | 4 (100.0) | One lost; one with positive HPV merged with HPV59 |
| 56 | 5 | 5 (100.0) | 5 (100.0) | 5 (100.0) | |
| 66 | 5 | 5 (100.0) | 5 (100.0) | 5 (100.0) | |
| 68 | 5 | 5 (100.0) | 5 (100.0) | 5 (100.0) | Two merged with HPV16 and remained positive; one lost, while all others were negative |
| 31 | 2 | 2 (100.0) | 2 (100.0) | 2 (100.0) | |
| 51 | 2 | 1 (50.0) | 2 (100.0) | 2 (100.0) | One with positive HPV at 6 months merged with HPV52 |
| 59 | 2 | 1 (50.0) | 1 (50.0) | 2 (100.0) | |
| CP8304 | 2 | 2 (100.0) | 2 (100.0) | 2 (100.0) | |
| 45 | 1 | 1 (100.0) | 1 (100.0) | 1 (100.0) | |
The HPV subtypes were sorted according to the number of infected patients in this study, from large to small, and multiple infections were counted repeatedly. The seroconversion rate of HR-HPV was determined according to the results of HPV genotyping, regardless of the outcomes of cytological examination. HPV, human papillomavirus.